The LuMon system provides real-time, radiation-free lung imaging for premature infants, children, and adults, helping clinicians tailor respiratory therapy at the bedside.
Sentec has received US Food and Drug Administration 510(k) clearance for its LuMon Electrical Impedance Tomography (EIT) system for premature infant, infant, adolescent, and adult patients—making it the first EIT technology in the United States available for premature infants and for spontaneously breathing patients, according to a release from the company.
The LuMon EIT System is designed to provide functional lung imaging directly at the bedside without using radiation. According to the company, this allows clinicians to better tailor respiratory therapy for patients in critical care environments, including neonatal, pediatric, and adult intensive care units.
While the system can monitor a range of patients, the company notes that premature infants and other patients in the NICU may benefit most from the technology’s insights.
“Neonatal patients present enormous complexity, especially for ventilation; there’s very little room for error, particularly in our smallest patients—and the consequences can follow these babies all their lives,” says Dr David Tingay, clinical neonatologist and respiratory physiotherapist at Royal Children’s Hospital in Melbourne, Australia, in a release. “Without EIT, there’s been no way for us to continuously see what is happening inside the lungs at the bedside to understand the impact of our interventions better as we perform them.”
Bedside Visualization of Lung Function
The LuMon system uses EIT to produce dynamic images of regional breathing variations. The technology works by sending gentle, alternating currents through the patient’s thorax via a soft, skin-friendly fabric belt. By measuring the resulting voltages, the system can help clinicians evaluate real-time responses to changes in ventilation from positioning, ventilator settings, or pharmaceuticals.
The ability to visualize lung function continuously at the bedside is intended to help clinicians make more individualized care decisions.
“EIT provides immediate imaging of regional lung function at the bedside,” Tingay says in the release. “That visualization helps us better understand each patient’s respiratory condition and determine the strategies we need to employ for their specific needs.”
The system is also CE-marked under EU MDR and registered with the TGA in Australia.
Photo caption: The LuMon EIT System delivers functional lung imaging directly at the NICU bedside—without radiation—helping clinicians better tailor therapy to each patient’s unique needs.
Photo credit: Sentec
